Home
overview

The conference listed on this page was held in February 2010. For information on the 2011 conference go to www.parallel-trade.com 

 

Parallel Trade Conference 2011

  

 

 

 

 
  • Explore strategies used to minimise opportunities for parallel traders
  • Discuss the potential for further development in EU legislation 
  • Understand the connection between parallel trade and counterfeiting
  • Hear about recent cases in the European Court of Justice
  • Network with industry associates and share experiences
 

 

Delegates at the third annual Pharmaceutical Parallel Trade conference included representatives from:

  • Allergan
  • Almirall
  • Alta Mar
  • AmeriSource Bergen
  • Astellas
  • Leo Pharmaceuticals
  • Lloyds Pharmacy
  • Medac GmbH
  • MPA Pharma
  • NanoGuardian
  • Napp Laboratories                        
  • Novartis
  • Roche Products Astrazeneca
  • Bayer Schering
  • Biogen IDEC
  • EMEA
  • Farma Mondo
  • State Agency of Medicines
  • Creativ-Ceutical
  • Delfarma
  • European Alliance for Access to Safe Medicines
  • European Association of Euro-Pharmaceutical Companies
  • GlaxoSmithKline
  • Global insight
  • Grunenthal GmbH
  • IMS Health
  • Johnson and Johnson
  • Latham & Watkins
  • Lek Pharm Co
  • Howrey LLP
  • Alcon Laboratories
  • Sanofi Aventis
  • Norgine

 

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Heinz Kobelt

Heinz Kobelt, Secretary General, European Association of Euro-Pharmaceutical Companies

9:10 QUALITY AND SAFETY ARE THE BUZZ-WORDS

Lisette Tiddens-Engwirda

Lisette Tiddens-Engwirda, Secretary General, Standing Committee of European Doctors (CPME)

  • Need for an unbroken control system from manufacturing through to end consumer
  • Danger  of counterfeit medicines to citizens of the European Union
  • Efficiency and enforceability of a joint EU directive
  • CPME position on combating counterfeit medicines
  • 9:50 PARALLEL TRADE IS AGAINST THE INTERESTS OF PATIENTS

    Dermot Glynn

    Dermot Glynn, Chairman, Europe Economics

  • Repackaging risks
  • Price convergence
  • Medicines cannot be afforded by low-income states
  • Profit and innovation reduced
  • 10:30 Morning Coffee

    11:00 PARALLEL DISTRIBUTION SEEN FROM THE INSIDE

    Heinz Kobelt

    Heinz Kobelt, Secretary General, European Association of Euro-Pharmaceutical Companies

  • Why EU Courts consider parallel trade a consumer benefit
  • Economics of parallel trade: all markets are exporters and importers at the same time
  • The impact of supply management systems
  • Repackaging: regulatory rules overlapped by trademark practice
  • Parallel distribution: a safe element of the legal supply chain
  • 11:40 PARALLEL TRADE AND FREE PRICING

    Rodrigo Osorio

    Rodrigo Osorio, Associate, Faus & Moliner

  • Free pricing is not dual pricing
  • How to operate in a free price environment
  • Do's and don’ts in price discrimination
  • Case law and practice in Spain
  • 12:20 Networking Lunch

    13:50 SUPPLY QUOTA SYSTEMS AND COMPETITION LAW: PITFALLS AND SOLUTIONS

    David Hull

    David Hull, Partner, Covington & Burling and Professor of Law, University of Liège

  • At what level can you set quotas?
  • How do quota systems interact with DTP systems?
  • How do you deal with shortages?
  • Does it make a difference if you are dominant?
  • 14:30 PARALLEL TRADE AND INTELLECTUAL PROPERTY LAW

    Robert Guthrie

    Robert Guthrie, Senior Associate , SJ Berwin & Co

  • Overview of UK and EU IP law concerning parallel trade
  • Internet sales - questions of jurisdiction and liability
  • The boundaries of consent
  • Repackaging - is the law now clear?
  • Strategies for rights owners
  • 15:10 Afternoon Tea

    15:40 WHO REALLY GAINS FROM PARALLEL TRADE?

    David Taylor

    David Taylor, Professor of Pharmaceutical and Public Health Policy, University of London

  • The story so far
  • Identifying beneficiaries
  • The effect of limiting Parallel Trade
  • Consumer welfare
  • 16:20 ABUSE OF DOMINANCE: CONTINUING CONFUSION

    Cormac Little

    Cormac Little, Head of Competition and Regulation Unit, William Fry Solicitors

  • Background to GSK Greece case
  • Is a refusal to supply parallel traders abusive?
  • What is an "ordinary" supply order?
  • Further uncertainty ahead
  • 17:00 Chairman’s closing remarks and close of day one

    8:30 Re-registration & Coffee

    9:00 Chairman's opening remarks

    Héctor Armengod

    Héctor Armengod, Associate Attorney, Latham & Watkins LLP

    9:10 IMPACT OF THE SINGLE MARKET IMPERATIVE

    Christopher Stothers

    Christopher Stothers, Counsel, Arnold & Porter (UK) LLP

  • Pharmaceuticals and the Single Market Imperative
  • Free Movement and Intellectual Property
  • Competition Law
  • Regulatory Law
  • 9:50 IMPACT OF THE GSK CASES ON PARALLEL IMPORTS OF PHARMACEUTICALS INTO EUROPE

    Despoina Mantzari

    Despoina Mantzari, Research Fellow, Jevons Institute of Competition Law and Economics

    10:30 Morning Coffee

    11:00 PARALLEL TRADE AFTER THE GLAXOSMITHKLINE CASES

    James Killick

    James Killick, Partner, White & Case LLP

  • Why the parallel trade cases?
  • What really happened in the GlaxoSmithKline cases?
  • What do the GSK cases mean for competition law?
  • Do we now have legal certainty?
  • 11:40 ANTI-COUNTERFEITING ELEMENTS OF THE PHARMACEUTICAL PACKAGE AND WHY PATIENT SAFETY IS PARAMOUNT

    Jim Thomson

    Jim Thomson, Chairman, European Alliance for Access to Safe Medicines

  • Why were new pharmaceutical security measures necessary?
  • Where the legislation right now and what is the timeframe for implementation?
  • Why is it important to preserve as well as to strengthen the proposals?
  • What about the internet?
  • The patient's role in making these proposals a success?
  • 12:20 Networking Lunch

    13:30 PARALLEL TRADE: WHERE DO WE STAND NOW?

    Thomas Bart

    Thomas Bart, Chief Operating Officer, Swiss Blood Stem Cells Foundation

  • Who is who?
  • Cui bono?
  • Where are the differences?
  • Can Switzerland be an example?
  • 14:10 PARALLEL TRADE AND COMPETITION LAW: RECENT DEVELOPMENTS AT EC AND EU MEMBER STATE LEVEL

    Héctor Armengod

    Héctor Armengod, Associate Attorney, Latham & Watkins LLP

  • ECJ Advocate General's opinion on GSK's dual pricing case
  • Recent developments in key Member States
  • Application of the concept of "extraordinary” and “ordinary” orders
  • Current and future EU policy on parallel trade
  • 14:50 COUNTERFEIT MEDICINES AND PARALLEL IMPORT

    Peter Bogaert

    Peter Bogaert, Managing Partner, Covington & Burling

  • The status of the Counterfeits Directive
  • The role of paralell imports and counterfeits
  • Safety features and repackaging activities
  • Relevance of trade marks
  • 15:30 Chairman’s Closing Remarks

    15:45 Afternoon Tea and Close of Conference

    +

    Workshops

    Out-Trading Traders: How to Out-Think Parallel Trade
    Workshop

    Out-Trading Traders: How to Out-Think Parallel Trade

    Crowne Plaza Hotel - St James
    9th February 2010
    London, United Kingdom

    Crowne Plaza Hotel - St James

    Buckingham Gate 45/51
    London SW1E 6AF
    United Kingdom

    Crowne Plaza Hotel - St James

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.